Circio Holding ASA (LTS:0RIS) Debt-to-Equity: -0.67 (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0RIS Circio Holding ASA LTS:0RIS
14 GF Score
Price kr13.76
! 3 Warning Signs
View Full Analysis

What is Circio Holding ASA Debt-to-Equity?

Circio Holding ASA LTS:0RIS +7.84% 14 Debt-to-Equity is -0.67 as of Dec. 2025. GuruFocus rates LTS:0RIS with a GF Score™ of 14/100. The stock has 3 warning signs investors should review. Among 957 Biotechnology companies, Circio Holding ASA ranks worse than 104493.1% on this metric.

Circio Holding ASA's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2025 was kr8.37 Mil. Circio Holding ASA's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2025 was kr0.00 Mil. Circio Holding ASA's Total Stockholders Equity for the quarter that ended in Dec. 2025 was kr-12.49 Mil. Circio Holding ASA's debt to equity for the quarter that ended in Dec. 2025 was -0.67.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Circio Holding ASA's Debt-to-Equity or its related term are showing as below:

LTS:0RIS' s Debt-to-Equity Range Over the Past 10 Years
Min: -1.39   Med: 0.12   Max: 24.72
Current: -0.67

During the past 13 years, the highest Debt-to-Equity Ratio of Circio Holding ASA was 24.72. The lowest was -1.39. And the median was 0.12.

LTS:0RIS's Debt-to-Equity is not ranked
in the Biotechnology industry.
Industry Median: 0.16 vs LTS:0RIS: -0.67

Circio Holding ASA  (LTS:0RIS) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


Circio Holding ASA Debt-to-Equity Related Terms


Circio Holding ASA Debt-to-Equity Historical Data

* Premium members only.

The historical data trend for Circio Holding ASA's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Circio Holding ASA Debt-to-Equity Chart

Circio Holding ASA Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Debt-to-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.14 24.72 -1.12 -1.39 -0.67

Circio Holding ASA Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.12 -0.81 -1.39 -0.90 -0.67

LTS:0RIS vs VRTX, REGN, RVMD: Debt-to-Equity Comparison

For the Biotechnology subindustry, Circio Holding ASA's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Circio Holding ASA Debt-to-Equity vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Circio Holding ASA's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Circio Holding ASA's Debt-to-Equity falls into.


LTS:0RIS
14GF Score
Circio Holding ASA LTS:0RIS
Debt-to-Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Circio Holding ASA Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Circio Holding ASA's Debt to Equity Ratio for the fiscal year that ended in Dec. 2025 is calculated as

Circio Holding ASA's Debt to Equity Ratio for the quarter that ended in Dec. 2025 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Debt-to-Equity →
What does a Debt-to-Equity of -0.67 mean?
Circio Holding ASA (LTS:0RIS) has a Debt-to-Equity of -0.67 as of Dec. 2025. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Circio Holding ASA and its competitors. According to the industry distribution chart, Circio Holding ASA ranks #999999 out of 957 companies in the Biotechnology industry.
Is Circio Holding ASA's Debt-to-Equity too high?
Circio Holding ASA's current Debt-to-Equity is -0.67. Based on the distribution chart, Circio Holding ASA ranks #999999 out of 957 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Circio Holding ASA has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Circio Holding ASA's Debt-to-Equity compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Circio Holding ASA ranks #999999 out of 957 companies for Debt-to-Equity. This places Circio Holding ASA in the lower half of its industry. The industry median Debt-to-Equity is 0.16. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Biotechnology company?
The median Debt-to-Equity among Biotechnology companies is 0.16, based on 957 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Circio Holding ASA and its competitors. For the Biotechnology industry, the median Debt-to-Equity is 0.16 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Circio Holding ASA's current Debt-to-Equity is -0.67. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Circio Holding ASA stock overvalued right now?
Circio Holding ASA (LTS:0RIS) has a current Debt-to-Equity of -0.67. The current Debt-to-Equity is -0.67. Circio Holding ASA's overall GF Score™ is 14/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For Circio Holding ASA (LTS:0RIS), the current Debt-to-Equity is -0.67 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Circio Holding ASA Business Description

Other Exchanges CRNA:NorwayTA50:Germany
Address c/o Mesh Community AS, Tordenskiolds Gate 2, Oslo, NOR, 0160
Circio Holding ASA is a biotechnology company developing circular RNA expression technology for gene and cell therapy applications. It has developed a circular RNA (circRNA) vector expression platform known as circVec, which is based on modular genetic constructs designed for circRNA production within target cells. The platform is being developed for applications including genetic medicine, cell therapy, and chronic disease treatment. The company's activities also include the development of RNA, DNA, and viral therapeutic technologies related to gene expression and protein production.
14GF Score

Get the complete analysis for LTS:0RIS

Debt-to-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr13.76
Price